{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:48:37Z","timestamp":1791643717766,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673950"],"award-info":[{"award-number":["81673950"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2019A1515011434"],"award-info":[{"award-number":["2019A1515011434"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.clim.2022.109139","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:35:21Z","timestamp":1664498121000},"page":"109139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["CXCL7 aggravates the pathological manifestations of neuromyelitis optica spectrum disorder by enhancing the inflammatory infiltration of neutrophils, macrophages and microglia"],"prefix":"10.1016","volume":"245","author":[{"given":"Zhuhe","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuewen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2022.109139_bb0005","series-title":"Nature Reviews Disease Primers","first-page":"85","article-title":"Neuromyelitis optica","volume":"6","author":"Jarius","year":"2020"},{"key":"10.1016\/j.clim.2022.109139_bb0010","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2022.109139_bb0015","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet (London, England)."},{"key":"10.1016\/j.clim.2022.109139_bb0020","doi-asserted-by":"crossref","first-page":"21962","DOI":"10.1038\/s41598-021-01294-3","article-title":"Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder","volume":"11","author":"Tradtrantip","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2022.109139_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577699","article-title":"C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD","volume":"360","author":"Pache","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2022.109139_bb0030","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/14712598.2021.1884223","article-title":"Targeting the complement system in neuromyelitis optica spectrum disorder","volume":"21","author":"Asavapanumas","year":"2021","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.clim.2022.109139_bb0035","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.clim.2022.109139_bb0040","first-page":"8","article-title":"New BBB model reveals that IL-6 blockade suppressed the BBB disorder, preventing onset of NMOSD","author":"Takeshita","year":"2021","journal-title":"Neurology Neuroimmunol. Neuroinflam."},{"key":"10.1016\/j.clim.2022.109139_bb0045","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/NDT.S185336","article-title":"Cytokines and chemokines expression in serum of patients with neuromyelitis optica","volume":"15","author":"Ai","year":"2019","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.clim.2022.109139_bb0050","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","article-title":"Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies","volume":"18","author":"Carnero Contentti","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.clim.2022.109139_bb0055","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12883-016-0622-3","article-title":"Increased plasma levels of epithelial neutrophil-activating peptide 78\/CXCL5 during the remission of neuromyelitis optica","volume":"16","author":"Yang","year":"2016","journal-title":"BMC Neurol."},{"key":"10.1016\/j.clim.2022.109139_bb0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1084\/jem.20141015","article-title":"Neutrophil-related factors as biomarkers in EAE and MS","volume":"212","author":"Rumble","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2022.109139_bb0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jns.2006.05.049","article-title":"Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitis","volume":"247","author":"Franciotta","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clim.2022.109139_bb0070","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/acn3.51094","article-title":"The CSF levels of neutrophil-related chemokines in patients with neuromyelitis optica","volume":"7","author":"Liu","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.clim.2022.109139_bb0075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12974-016-0746-9","article-title":"Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G","volume":"13","author":"Felix","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.clim.2022.109139_bb0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2014.02.011","article-title":"Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59","volume":"53","author":"Zhang","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2022.109139_bb0085","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.clim.2022.109139_bb0090","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1111\/bph.15178","article-title":"ARRIVE 2.0 and the British Journal of Pharmacology: updated guidance for 2020","volume":"177","author":"Lilley","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.clim.2022.109139_bb0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2019.04.020","article-title":"Interleukin-1 receptor associated kinase (IRAK)-M -mediated type 2 microglia polarization ameliorates the severity of experimental autoimmune encephalomyelitis (EAE)","volume":"102","author":"Liu","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2022.109139_bb0100","article-title":"High level of serum and cerebrospinal fluid of heparan sulfate and hyaluronic acid might be a biomarker of severity of neuromyelitis optica","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109139_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051603","article-title":"Regulation of AQP4 in the central nervous system","volume":"21","author":"Vandebroek","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2022.109139_bb0110","doi-asserted-by":"crossref","first-page":"24334","DOI":"10.1038\/s41598-021-03694-x","article-title":"Cx43 carboxyl terminal domain determines AQP4 and Cx30 endfoot organization and blood brain barrier permeability","volume":"11","author":"Cibelli","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2022.109139_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/nu13093216","article-title":"Dietary supplement enriched in antioxidants and omega-3 promotes glutamine synthesis in M\u00fcller cells: a key process against oxidative stress in retina","volume":"13","author":"Ardourel","year":"2021","journal-title":"Nutrients."},{"key":"10.1016\/j.clim.2022.109139_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108490","article-title":"Microglia increase tight-junction permeability in coordination with M\u00fcller cells under hypoxic condition in an in vitro model of inner blood-retinal barrier","volume":"205","author":"Inada","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.clim.2022.109139_bb0125","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00401-021-02366-4","article-title":"Complement component 3 from astrocytes mediates retinal ganglion cell loss during neuroinflammation","volume":"142","author":"Gharagozloo","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.clim.2022.109139_bb0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.brainres.2011.06.005","article-title":"Glial cell response and iNOS expression in the optic nerve head and retina of the rat following acute high IOP ischemia-reperfusion","volume":"1403","author":"Cho","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.clim.2022.109139_bb0135","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1016\/j.cell.2021.06.031","article-title":"Preservation of vision after CaMKII-mediated protection of retinal ganglion cells","volume":"184","author":"Guo","year":"2021","journal-title":"Cell."},{"key":"10.1016\/j.clim.2022.109139_bb0140","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41582-021-00568-8","article-title":"Hope for patients with neuromyelitis optica spectrum disorders - from mechanisms to trials","volume":"17","author":"Pittock","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.clim.2022.109139_bb0145","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/ana.22551","article-title":"Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms","volume":"70","author":"Zhang","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2022.109139_bb0150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.exer.2013.12.010","article-title":"Sera from patients with seropositive neuromyelitis optica spectral disorders caused the degeneration of rodent optic nerve","volume":"119","author":"Matsumoto","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.clim.2022.109139_bb0155","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/WNR.0b013e32832776f4","article-title":"Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum","volume":"20","author":"Kinoshita","year":"2009","journal-title":"Neuroreport."},{"key":"10.1016\/j.clim.2022.109139_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.727750","article-title":"Low frequency ultrasound with injection of NMO-IgG and complement produces lesions different from experimental autoimmune encephalomyelitis mice","volume":"12","author":"Xiang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109139_bb0165","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cell.2020.03.037","article-title":"Targeting aquaporin-4 subcellular localization to treat central nervous system edema","volume":"181","author":"Kitchen","year":"2020","journal-title":"Cell."},{"key":"10.1016\/j.clim.2022.109139_bb0170","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1038\/s41467-020-18115-2","article-title":"Circadian control of brain glymphatic and lymphatic fluid flow","volume":"11","author":"Hablitz","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2022.109139_bb0175","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1007\/s12035-021-02491-x","article-title":"Aquaporin-4 removal from the plasma membrane of human M\u00fcller cells by AQP4-IgG from patients with neuromyelitis optica induces changes in cell volume homeostasis: the first step of retinal injury?","volume":"58","author":"Netti","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.clim.2022.109139_bb0180","series-title":"Multiple Sclerosis and Related Disorders","article-title":"Optical coherence tomography in neuromyelitis optica spectrum disorder and multiple sclerosis: a population-based study","volume":"47","author":"Ashtari","year":"2021"},{"key":"10.1016\/j.clim.2022.109139_bb0185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jns.2017.11.017","article-title":"High resolution retinal scanning reveals regional structural differences between MS and NMOSD optic neuritis regardless of antibody status","volume":"384","author":"Bertsch-Gout","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clim.2022.109139_bb0190","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jamaneurol.2013.1832","article-title":"Microcystic inner nuclear layer abnormalities and neuromyelitis optica","volume":"70","author":"Gelfand","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clim.2022.109139_bb0195","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000514441","article-title":"Neuroprotective factors of the retina and their role in promoting survival of retinal ganglion cells: a review","volume":"64","author":"Fudalej","year":"2021","journal-title":"Ophthalmic Res."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622002200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622002200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:11:17Z","timestamp":1761495077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661622002200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":39,"alternative-id":["S1521661622002200"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2022.109139","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CXCL7 aggravates the pathological manifestations of neuromyelitis optica spectrum disorder by enhancing the inflammatory infiltration of neutrophils, macrophages and microglia","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2022.109139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109139"}}